Half As Many People Are Trying Heroin, But Marijuana Use Grows
An annual government survey of drug use and health shows a dramatic drop in the number of people who tried heroin but an uptick in pot use.
The independent source for health policy research, polling, and news.
6,581 - 6,600 of 15,445 Results
An annual government survey of drug use and health shows a dramatic drop in the number of people who tried heroin but an uptick in pot use.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
In response to a spike in syphilis and gonorrhea cases, one Oregon county is sending medical sleuths to break the bad news in person. Some people have no idea they've been exposed to an infection.
The controversy over the death toll from Hurricane Maria continues as the president tweets that the official estimate adopted by territory officials is a political ploy.
In this episode of KHN’s “What the Health?” Sarah Jane Tribble of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call talk about the Food and Drug Administration’s latest actions to address teenagers’ use of e-cigarettes, Arkansas’ Medicaid work requirements and news about the uninsured from the latest federal Census report.
Embattled drugmaker Purdue Pharma defends OxyContin as some insurers are dropping the drug in favor of other abuse-deterrent opioid painkillers.
Doctors and hospitals love to talk about the patients they’ve saved with precision medicine, and reporters love to write about them. But the people who die still vastly outnumber the rare successes.
With Hurricane Florence predicted to slam the Southeast's coastline Friday, health officials scramble to dodge the storm and keep older residents safe.
The Census Bureau reports that the nation’s uninsurance rate was 8.8 percent in 2017 but notes that the rate did increase in 14 states.
Dr. Prudence Hall has made a name for herself in the field of “bioidentical hormones” — plant-based compounds purportedly customized for each patient’s needs. Experts say the popular approach is unproven; California regulators say she was grossly negligent in her care of two patients.
As HHS decided to cut $1.6 billion in drug payments to hospitals, it weighed thousands of comments generated by a pharmaceutical-funded advocacy group.
The wide-ranging law has the potential to blindside many consumers whose health care comes from company and union health plans that are “self-funded,” meaning they pay claims out of their own funds.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes, and 26 when he died. He couldn't afford $1,300 per month for his insulin and other diabetes supplies. So he tried to stretch the doses.
Desperate for help in finding a lifesaving drug for a fatal genetic disease, families banded together to fund early research and then worked with drug companies on clinical trials and marketing. Yet, this small patient advocacy group is stunned by pharma’s pricing.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Mary Agnes Carey of Kaiser Health News, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico talk about the latest court challenge to the Affordable Care Act, nomination hearings for Supreme Court nominee Brett Kavanaugh and news from the reproductive health front. Plus, Rovner interviews Chad Terhune about the latest KHN/NPR “Bill of the Month” installment.
Oral arguments got underway in federal court in Fort Worth, Texas, on Wednesday in the lawsuit brought by 20 Republican states seeking to declare the Affordable Care Act unconstitutional.
Is there anything families can do to fight these evictions?
At least 11 states are going to try to tax opioids despite pushback from pharmaceutical companies.
What exactly is sepsis, and why is it so dangerous? Who is most vulnerable? And what are the signs? KHN explains in this video.
© 2026 KFF